Selecting a new Regulatory Information Management (RIM) platform is one of the most significant technology decisions a Life Sciences organization will make. The chosen platform will influence regulatory operations, compliance, data governance, and business agility for years to come.

As organizations expand product portfolios, enter new markets, and adapt to evolving regulatory requirements, many begin asking the same question: Does our current RIM environment still support our business, or is it time to modernize?

Organizations quickly discover that selecting a platform is only one part of a much larger challenge..

The Greatest Risks Are Organizational, Not Technical

Most regulatory organizations recognize the challenges limiting operational efficiencies. Regulatory data is spread across multiple systems, reporting requires significant manual effort, and teams follow different processes across regions or business units. The result is inconsistent information, limited visibility, and reduced confidence in regulatory operations.

While these issues often appear to be technology limitations, they are typically the result of years of organizational evolution. As companies expand into new markets, acquire products, adapt to changing regulations, and grow their teams, processes naturally evolve. Local workarounds emerge, governance practices drift, and information is managed differently across functions and regions. Over time, this complexity becomes embedded within the technology landscape itself.

These inconsistencies often remain hidden until requirements gathering or implementation activities begin. At that point, differences between teams, regions, and business units become impossible to ignore. New software alone cannot resolve these underlying challenges. Because regulatory information supports product planning, market expansion, compliance, and strategic decision-making, inconsistent processes and unreliable data quickly become business risks.  

The objective is not simply to replace technology; it is to modernize how people, processes, information, and technology work together. Achieving this requires a different approach.

Change Your Focus: Goals, Not Feature Lists

Successful modernization begins by asking a different question. Instead of asking which platform has the best capabilities, organizations should ask what they are trying to achieve. Without clearly defined future-state objectives, teams become focused on vendor demonstrations, feature comparisons, and technical evaluations rather than business outcomes they need to deliver.

The most successful organizations first understand their current state, identify operational inefficiencies, define future capabilities, and engage stakeholders across Regulatory Affairs, Regulatory Operations, IT, and business leadership. This confirms modernization goals reflect enterprise priorities rather than the needs of a single function.

With this foundation in place, technology is evaluated against business objectives, not feature checklists, resulting in solutions that support long-term regulatory strategy rather than simply replacing existing systems.

SelectAssist℠: Proven Structure for a Complex Decision

Few organizations undertake RIM modernization frequently enough to develop a repeatable approach. Regulatory leaders may oversee one or two major platform transformations during their careers, yet the decisions they make influence operations for years.

SelectAssist was developed by fme to help Life Sciences organizations navigate these decisions through a structured, vendor-neutral methodology. Through executive interviews, stakeholder workshops, process and governance assessments, current-state analysis, and business case development, we establish a clear understanding of your organization’s operating model, future-state objectives, and critical business requirements.

Using this foundation, we objectively evaluate and score RIM platforms against your defined criteria, providing leadership with a clear understanding of each solution’s strengths, tradeoffs, risks, and long-term fit. Rather than selecting technology based on demonstrations or feature lists, organizations make informed decisions aligned with their regulatory strategy, operating model, and future growth.

Because successful modernization depends on more than technology, SelectAssist also evaluates the people, processes, governance, data, and organizational readiness required to support a successful transformation.

If your organization is evaluating a new RIM platform, or simply wants confidence that it is asking the right questions before engaging software vendors, we’d welcome the opportunity to discuss your modernization goals. Download the SelectAssist datasheet to learn how our proven methodology helps Life Sciences organizations make informed, objective platform decisions with confidence.

About the Author

Meghan Carr, PMP

Meghan Carr, PMP, is Vice President of Commercial Operations at fme Life Sciences, leading global commercial strategy for regulated content and data modernization initiatives across the pharmaceutical and biotechnology industries. With more than 20 years of experience spanning Regulatory, Clinical, and Quality, she has worked with many of the world’s leading life sciences organizations on complex digital transformation programs.

Throughout her career with leading global software vendors, implementation partners, and technology service providers, Meghan has supported hundreds of technology evaluations, proposals, and transformation initiatives. This experience has provided a unique perspective on the platform selection process and the organizational factors that ultimately determine modernization success.